Skip to main content
logo
CanSino Biologics Inc. (HKG:6185)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
34.14
-0.44 (-1.27%)
Apr 21, 2026, 4:08 PM HKT

CanSino Biologics Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
13,76412,63211,61012,51427,69066,111
Market Cap Growth
19.26%8.81%-7.23%-54.81%-58.12%-11.15%
Enterprise Value
12,25611,14010,30210,61123,86858,920
Last Close Price
34.5834.9231.5023.5566.75177.89
PE Ratio
282.50407.26---28.13
Forward PE
38.5845.28---11.16
PS Ratio
11.5810.6312.8931.8123.6812.53
PB Ratio
2.502.292.222.153.386.30
P/TBV Ratio
2.602.382.282.213.756.89
P/FCF Ratio
-----63.60
P/OCF Ratio
135.95124.77---26.27
EV/Sales Ratio
10.319.3711.4426.9720.4111.16
EV/EBITDA Ratio
134.05130.77---25.96
EV/EBIT Ratio
-----26.91
EV/FCF Ratio
-72.02----56.68
Debt / Equity Ratio
0.260.260.410.510.370.16
Debt / EBITDA Ratio
15.6815.68---0.74
Debt / FCF Ratio
-----1.62
Net Debt / Equity Ratio
-0.27-0.27-0.24-0.27-0.45-0.75
Net Debt / EBITDA Ratio
-17.70-17.707.800.972.46-3.46
Net Debt / FCF Ratio
8.868.861.910.941.11-7.57
Asset Turnover
0.140.140.100.030.090.46
Inventory Turnover
0.840.840.831.551.572.48
Quick Ratio
3.323.322.361.862.332.78
Current Ratio
3.673.672.542.022.643.25
Return on Equity (ROE)
0.56%0.56%-7.52%-31.40%-12.22%26.09%
Return on Assets (ROA)
-0.73%-0.73%-2.52%-10.36%-8.03%11.97%
Return on Invested Capital (ROIC)
-2.45%-2.40%-9.21%-43.85%-48.83%108.45%
Return on Capital Employed (ROCE)
-1.40%-1.40%-5.60%-25.50%-17.50%19.80%
Earnings Yield
0.23%0.25%-3.47%-13.05%-3.71%3.55%
FCF Yield
-1.24%-1.35%-5.73%-13.37%-11.95%1.57%
Dividend Yield
-----0.55%
Payout Ratio
159.68%159.68%---0.74%
Buyback Yield / Dilution
-2.32%-2.32%-0.38%0.17%0.08%-7.26%
Total Shareholder Return
-2.32%-2.32%-0.38%0.17%0.08%-6.70%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.